FDA Had A Public Discussion Regarding Drug Compounders
January 8, 2013
The Food and Drug Administration had a public discussion with public health officials from 50 states on how best to strengthen regulation of compounding pharmacies. This comes after a multi-state outbreak of fungal meningitis due to contaminated steroid injections from a compounding pharmacy.
Topics:
Health Medical Pharma, Disaster Accident, Social Issues, Health, Pharmaceutical sciences, Pharmacology, Environment, McGuff Companies, Food and Drug Administration, Pharmacy, Compounding, Clinical research
